CALCIUM FOLATE
Poststroke/CVA Hemiparesis
Taipei Medical University WanFang HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Poststroke/CVA Hemiparesis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(1-(2-tetrahydrofuryl)-5-fluorouracil) and uracil 1:4 Taipei Medical University WanFang Hospital | N/A | D |
Same molecule, other indications
CALCIUM FOLATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →